It takes upto to 15 years and multimillion dollar investments to patent and market one successful drug for pharmaceutical and biotech industry. Trying to make the sure that the scientists receive the best R&D support possible companies have looked at outsourcing and insourcing and everything else.
And the new boy in the buzz world is “crowdsourcing” claiming businesses a way to tap into a larger, global community of scientists and R&D exeutives.
Crowdsourcing is a business model in which a company or institution takes a job traditionally performed by a designated agent (usually an employee) and outsources it to an undefined, generally large group of people in the form of an open call over the Internet. The work is compensated with little or no pay in most cases. However, in a few examples the labor is well-compensated .
Did that made sense it sounds like open source in biotech fields. but hold on your horses, it not that straight forward, remember Nature has published an article about open source in drug discover industry some time back, there is big list of things that makes it a difficult project.
But there is one company that has pulled it off successfully set up by drug giant Eli Lilly in 2001, for its projects Innocentive is one such crowdsourcer, So far, chemicals and life sciences have been the main users of crowdsourcers, offering rewards of up to $1m if they are successful. There are other places , such as Nine Sigma and Yet2.com and Scienteur, offer similar models.
Another firm Procter & Gamble P&G also works with Nine Sigma , YourEncore andYet2.com and Innocentive
Boeing , Dow Chemical , Eli Lilly and Procter & Gamble , Solvay are number of companies that have benefited fro this model ,
IT industry has grown to this level because people were willing to share data and collaborate , ofcourse there is much difference between IT and biological industry . But will scientists from life science industry would do it- So far the answer is No- may in future they might be more open to such needs
Read Related studies Further at
The Value of Openness in Scientific Problem Solving
Can open-source R&D reinvigorate drug research a nature Review
Open source in Biotechnology
Online data Sharing for scientists – Will they accept it
Filed under: bioinformatics blog, drug development, drug discoverry, microarray blog, Online Data sharing, open access database, open source in biotechnoligy, outsourcing, science blog, six degrees of separation, web2.0 | 2 Comments »